TrialThe oncologist2023
Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study.
Astrid Lipplaa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
TrialThe oncologist2023
Astrid Lipplaa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.